NovoMatrix in Gingival Recession Coverage: Case Series
ConditionGingival Recession, Generalized
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-70
SponsorSemmelweis University
About this trial
Twenty patients seeking treatment for gingival recession coverage, ranging from 20-70 years of age with multiple Miller Class I or II buccal gingival recessions (depth≥3 mm, at least 3 adjacent teeth) will be recruited for this study. Five patients within the study patient pool looking for further orthodontic or restorative treatment that requires removal of one single rooted tooth within the study site of interest will be selected for histological sample removal. All procedures performed in this study will be executed according to established routine protocols, with the exception of block biopsies of one hopeless tooth per patient (total of 5 patients) at 6 months.
Eligibility criteria
Qualifiers
Male or female, between 20-70 years of age, who request gingival augmentation or recession coverage.
Subjects who are willing to sign an informed consent, participate and return for follow-up visits.
Subjects without significant medical history and currently not on medications that might complicate treatment outcomes.
Subjects demonstrating good oral hygiene (FMPS, FMBS less than 20%).
Disqualifiers
Subjects who do not meet all the inclusion criteria or who will not cooperate with the protocol schedule.
Subjects who received and failed a previously placed autogenous graft.
Subjects who have significant untreated periodontal disease, caries, infection or chronic inflammation in the oral cavity within two adjacent tooth positions of the clinical trial area.
Subjects who have used nicotine-containing products within 3 weeks prior to surgery.
Trial design
Treatments tested in this trial
- Subperiostal tunnel in conjunction with Novomatrix
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov